Oncostatin M promotes mesenchymal stem cell-stimulated tumorgrowth through a paracrine mechanism involving periostin and TGFBI

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 8, 2013, Pages 1869-1877

  Lee, Mi Jeong ^a,b   Heo, Soon Chul ^a,b   Shin, Sang Hun ^a,b   Kwon, Yang Woo ^a,b   Do, Eun Kyoung ^a,b   Suh, Dong Soo ^b   Yoon, Man Soo ^b   Kim, Jae Ho ^a,b,c  

^a Medical Research Center for Ischemic Tissue Regeneration and Medical Research Institute   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Pusan National University Yangsan Hospital   (South Korea)

Author keywords

Mesenchymal stem cells; OSM; Periostin; Prostate cancer; TGFBI

Indexed keywords

LUCIFERASE; ONCOSTATIN M; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

ADIPOSE TISSUE CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; METASTASIS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 84879825630     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.05.027     Document Type: Article

References (50)

1. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biolog-ical characterization. International Journal of Biochemistry and Cell Biology 2004;36(4):568-84.. (Pubitemid 38324589)
2. Borsellino N, Bonavida B, Ciliberto G, Toniatti C, Travali S, D'Alessandro N. Blockingsignaling through the Gp130 receptor chain by interleukin-6 and oncostatinM inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity. Cancer 1999;85(1):134-44.. (Pubitemid 29031367)
3. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascularorigin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3(3):301-13..
4. Culig Z, Steiner H, Bartsch G, Hobisch A. Interleukin-6 regulation of prostate cancercell growth. Journal of Cellular Biochemistry 2005;95(3):497-505.. (Pubitemid 41420180)
5. Cunha GR, Hayward SW, Wang YZ, Ricke WA. Role of the stromal microenvi-ronment in carcinogenesis of the prostate. International Journal of Cancer 2003;107(1):1-10.. (Pubitemid 37100079)
6. De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are driversof invasive cancer growth. International Journal of Cancer 2008;123(10):2229-38..
7. Fossey SL, Bear MD, Kisseberth WC, Pennell M, London CA. Oncostatin M promotesSTAT3 activation, VEGF production, and invasion in osteosarcoma cell lines. BMCCancer 2011;11:125..
8. Franco OE, Hayward SW. Targeting the tumor stroma as a novel thera-peutic approach for prostate cancer. Advances in Pharmacology 2012;65:267-313..
9. Friedrich M, Hoss N, Stogbauer F, Senner V, Paulus W, Ringelstein EB, et al. Completeinhibition of in vivo glioma growth by oncostatin M. Journal of Neurochemistry 2001;76(5):1589-92.. (Pubitemid 32198263)
10. Godoy-Tundidor S, Cavarretta IT, Fuchs D, Fiechtl M, Steiner H, Friedbichler K, et al. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22 Rv1 cells through the signaling pathways of p38 mitogen-activated proteinkinase and phosphatidylinositol 3-kinase. Prostate 2005;64(2):209-16.. (Pubitemid 40791771)
11. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA: A Cancer Journal for Clinicians 2000;50(1):7-33.. (Pubitemid 30072093)
12. Heo SC, Lee KO, Shin SH, Kwon YW, Kim YM, Lee CH, et al. Periostin medi-ates human adipose tissue-derived mesenchymal stem cell-stimulated tumorgrowth in a xenograft lung adenocarcinoma model. Biochimica et Biophysica Acta 2011;1813(12):2061-70..
13. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, et al. Identification and characterization of a novel protein, periostin, with restrictedexpression to periosteum and periodontal ligament and increased expressionby transforming growth factor beta. Journal of Bone and Mineral Research 1999;14(7):1239-49.. (Pubitemid 29314070)
14. Jeon ES, Lee IH, Heo SC, Shin SH, Choi YJ, Park JH, et al. Mesenchymal stem cells stimu-late angiogenesis in a murine xenograft model of A549 human adenocarcinomathrough an LPA1 receptor-dependent mechanism. Biochimica et Biophysica Acta 2010;1801(11):1205-13..
15. Jeon ES, Moon HJ, Lee MJ, Song HY, Kim YM, Cho M, et al. Cancer-derived lysophos-phatidic acid stimulates differentiation of human mesenchymal stem cells tomyofibroblast-like cells. Stem Cells 2008;26(3):789-97..
16. Karlou M, Tzelepi V, Efstathiou E. Therapeutic targeting of the prostate cancermicroenvironment. Nature Reviews Urology 2010;7(9):494-509..
17. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchy-mal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449(7162):557-63.. (Pubitemid 47525152)
18. Kim BY, Olzmann JA, Choi SI, Ahn SY, Kim TI, Cho HS, et al. Corneal dystrophy-associated R124H mutation disrupts TGFBI interaction with periostin and causes mislocalization to the lysosome. Journal of Biological Chemistry 2009;284(29):19580-91..
19. Kudo Y, Siriwardena BS, Hatano H, Ogawa I, Takata T. Periostin: novel diag-nostic and therapeutic target for cancer. Histology and Histopathology 2007;22(10):1167-74.. (Pubitemid 47470310)
20. Kyutoku M, Taniyama Y, Katsuragi N, Shimizu H, Kunugiza Y, Iekushi K, et al. Roleof periostin in cancer progression and metastasis: inhibition of breast cancerprogression and metastasis by anti-periostin antibody in a murine model. Inter-national Journal of Molecular Medicine 2011;28(2):181-6..
21. Lee MJ, Song HY, Kim MR, Sung SM, Jung JS, Kim JH, et al. stimulates expressionof stromal-derived factor-1 in human mesenchymal stem cells. International Journal of Biochemistry and Cell Biology 2007;39(3):650-9.. (Pubitemid 46096802)
22. Lee YJ, Kim IS, Park SA, Kim Y, Lee JE, Noh DY, et al. Periostin-binding DNAaptamer inhibits breast cancer growth and metastasis. Molecular Therapy 2013;21(5):1004-13..
23. Li C, Ahlborn TE, Kraemer FB, Liu J. Oncostatin M-induced growth inhibition and morphological changes of MDA-MB231 breast cancer cells are abolished byblocking the MEK/ERK signaling pathway. Breast Cancer Research and Treat-ment 2001;66(2):111-21.. (Pubitemid 32521417)
24. Li Q, Zhu J, Sun F, Liu L, Liu X, Yue Y. Oncostatin M promotes proliferation of ovariancancer cells through signal transducer and activator of transcription 3. Interna-tional Journal of Molecular Medicine 2011;28(1):101-8..
25. Ma C, Rong Y, Radiloff DR, Datto MB, Centeno B, Bao S, et al. Extracellular matrixprotein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cellextravasation. Genes and Development 2008;22(3):308-21.. (Pubitemid 351214273)
26. Malanchi I, Santamaria-Martinez A, Susanto E, Peng H, Lehr HA, Delaloye JF, et al. Interactions between cancer stem cells and their niche govern metastatic colo-nization. Nature 2012;481(7379):85-9..
27. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Research 2008;68(11):4331-9..
28. Mori S, Murakami-Mori K, Bonavida B. Oncostatin M (OM) promotes the growthof DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through thesignaling of the OM specific receptor. Anticancer Research 1999;19(2A):1011-5.. (Pubitemid 29257530)
29. Morra L, Moch H. Periostin expression and epithelial-mesenchymal transition incancer: a review and an update. Virchows Archiv 2011;459(5):465-75..
30. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. New England Journal ofMedicine 2003;349(4):366-81.. (Pubitemid 36886244)
31. Nummela P, Lammi J, Soikkeli J, Saksela O, Laakkonen P, Holtta E. Transforminggrowth factor beta-induced (TGFBI) is an anti-adhesive protein regulat-ing the invasive growth of melanoma cells. American Journal of Pathology 2012;180(4):1663-74..
32. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promotetumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005;121(3):335-48.. (Pubitemid 40692295)
33. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-7.. (Pubitemid 29282067)
34. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276(5309):71-4.. (Pubitemid 27161245)
35. Ruan K, Bao S, Ouyang G. The multifaceted role of periostin in tumorigenesis. Cellularand Molecular Life Sciences 2009;66(14):2219-30..
36. Shin SH, Kim J, Heo SC, Kwon YW, Kim YM, Kim IS, et al. Proteomic identification ofbetaig-h3 as a lysophosphatidic acid-induced secreted protein of human mes-enchymal stem cells: paracrine activation of A549 lung adenocarcinoma cellsby betaig-h3. Molecular and Cellular Proteomics 2012;11(2):M111..
37. Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons PJ. Mesenchymalstem cells. Archives of Medical Research 2003;34(6):565-71..
38. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloningand sequence analysis of betaig-h3, a novel gene induced in a human adenocar-cinoma cell line after treatment with transforming growth factor-beta. DNA andCell Biology 1992;11(7):511-22..
39. Sun C, Zhao X, Xu K, Gong J, Liu W, Ding W, et al. Periostin: a promising target oftherapeutical intervention for prostate cancer. Journal of Translational Medicine 2011;9:99..
40. Tanaka M, Miyajima A. Oncostatin M, a multifunctional cytokine. Reviews of Physi-ology Biochemistry and Pharmacology 2003;149:39-52..
41. Thapa N, Lee BH, Kim IS. TGFBIp/betaig-h3 protein: a versatile matrix moleculeinduced by TGF-beta. International Journal of Biochemistry and Cell Biology 2007;39(12):2183-94..
42. Tischler V, Fritzsche FR, Wild PJ, Stephan C, Seifert HH, Riener MO, et al. Periostinis up-regulated in high grade and high stage prostate cancer. BMC Cancer 2010;10:273..
43. Tsunoda T, Furusato B, Takashima Y, Ravulapalli S, Dobi A, Srivastava S, et al. The increased expression of periostin during early stages of prostatecancer and advanced stages of cancer stroma. Prostate 2009;69(13):1398-403..
44. Ween MP, Lokman NA, Hoffmann P, Rodgers RJ, Ricciardelli C, Oehler MK. Transfor-ming growth factor-beta-induced protein secreted by peritoneal cells increasesthe metastatic potential of ovarian cancer cells. International Journal of Cancer 2011;128(7):1570-84..
45. Weiss TW, Simak R, Kaun C, Rega G, Pfluger H, Maurer G, et al. Oncostatin M and IL-6induce u-PA and VEGF in prostate cancer cells and correlate in vivo. Anticancer Research 2011;31(10):3273-8..
46. Wu SQ, Lv YE, Lin BH, Luo LM, Lv SL, Bi AH, et al. Silencing of periostininhibits nicotine-mediated tumor cell growth and epithelial- mesenchymaltransition in lung cancer cells. Molecular Medicine Reports 2013;7(3):875-80..
47. Ye H, Cheng J, Tang Y, Liu Z, Xu C, Liu Y, et al. Human bone marrow-derived mesenchymal stem cells produced TGFbeta contributes to progres-sion and metastasis of prostate cancer. Cancer Investigation 2012;30(7):513-8..
48. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ. OncostatinM: a growth regulator produced by differentiated histiocytic lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America 1986;83(24):9739-43.. (Pubitemid 17223432)
49. Zhu M, Saxton RE, Ramos L, Chang DD, Karlan BY, Gasson JC, et al. Neutralizingmonoclonal antibody to periostin inhibits ovarian tumor growth and metastasis. Molecular Cancer Therapeutics 2011;10(8):1500-8..
50. Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu J, et al. Mesenchymal stem cells derivedfrom bone marrow favor tumor cell growth in vivo. Experimental and Molecular Pathology 2006;80(3):267-74..